KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Sabra Health Care REIT (SBRA) Shares Outstanding (Diluted Average) (2016 - 2022)

Sabra Health Care REIT (SBRA) has 15 years of Shares Outstanding (Diluted Average) data on record, last reported at $244.5 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 3.58% year-over-year to $244.5 million; the TTM value through Dec 2025 reached $244.5 million, up 3.58%, while the annual FY2025 figure was $244.5 million, 3.58% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $244.5 million in Q4 2025 per SBRA's latest filing, up from $241.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $244.5 million in Q4 2025 and bottomed at $212.6 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $231.1 million, with a median of $232.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): grew 8.91% in 2022, then dropped 0.17% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $219.1 million in 2021, then rose by 5.42% to $230.9 million in 2022, then increased by 0.8% to $232.8 million in 2023, then rose by 1.4% to $236.0 million in 2024, then rose by 3.58% to $244.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $244.5 million in Q4 2025, $241.6 million in Q3 2025, and $240.9 million in Q2 2025.